SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001839882-23-006682
Filing Date
2023-03-14
Accepted
2023-03-14 17:25:47
Documents
19
Period of Report
2023-03-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K admp-8k_022523.htm   iXBRL 8-K 39188
2 FORM OF COMMON STOCK PURCHASE WARRANT ex4-1.htm EX-4.1 174665
3 FORM OF PREFUNDED COMMON STOCK PURCHASE WARRANT ex4-2.htm EX-4.2 155367
4 OPINION OF LATHAM & WATKINS, LLP ex5-1.htm EX-5.1 19713
5 FORM OF SECURITIES PURCHASE AGREEMENT ex10-1.htm EX-10.1 266392
6 PRESS RELEASE ex99-1.htm EX-99.1 13205
10 GRAPHIC image_001.jpg GRAPHIC 7890
11 GRAPHIC admp-002.jpg GRAPHIC 1352
  Complete submission text file 0001839882-23-006682.txt   1007756

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT admp-20230314.xsd EX-101.SCH 3203
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT admp-20230314_lab.xml EX-101.LAB 34240
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT admp-20230314_pre.xml EX-101.PRE 22343
13 EXTRACTED XBRL INSTANCE DOCUMENT admp-8k_022523_htm.xml XML 3589
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 23732112
SIC: 2834 Pharmaceutical Preparations